PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1725.48%
Revenue growth above 1.5x ECL.AX's 152.53%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2308.06%
Gross profit growth above 1.5x ECL.AX's 112.17%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
51.14%
Positive EBIT growth while ECL.AX is negative. John Neff might see a substantial edge in operational management.
51.14%
Positive operating income growth while ECL.AX is negative. John Neff might view this as a competitive edge in operations.
37.21%
Positive net income growth while ECL.AX is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.82%
Share reduction while ECL.AX is at 0.42%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-18.99%
Reduced diluted shares while ECL.AX is at 100128471.43%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
45.04%
Positive OCF growth while ECL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
14.87%
Positive FCF growth while ECL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-89.32%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-78.78%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-70.24%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-45.41%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
580.42%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
-101.15%
Negative 10Y net income/share CAGR while ECL.AX is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
23.00%
Below 50% of ECL.AX's 355.60%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
87.68%
Positive short-term CAGR while ECL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.84%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
7.77%
Inventory growth well above ECL.AX's 4.60%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.48%
Positive asset growth while ECL.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1432.90%
BV/share growth above 1.5x ECL.AX's 2.87%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
6.03%
We have some new debt while ECL.AX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-50.09%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
145.68%
We expand SG&A while ECL.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.